Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q2- Text added to 2022 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
absence, American, Bayesian, CAR, care, committee, concurrently, consent, consented, consenting, COVID, denied, denying, detected, dexamethasone, DRI, economy, employed, entitled, expansion, fixed, front, futility, global, graduation, hazard, Hematology, HR, imbalance, implied, independent, infective, inflation, infusion, kill, killing, labeling, lack, largest, LP, maximum, methodology, mg, molecular, oxygen, payout, persuasive, phenotype, preferential, prespecified, promise, prorated, protocol, ratio, reaching, recoup, recourse, relapse, remdesivir, revaluation, RSU, shorten, shortfall, skewed, slate, Society, statistically, strategy, streamline, superior
Valuein 2022 Q2 filing- Value in 2022 Q3 filing
Original filings
Filing view